Abstract
Recently, the coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, has spread worldwide. Although nearly all patients incur mild-to-moderate disease from this viral infection, some develop severe manifestations with a poor prognosis. COVID-19 can also induce autoimmune disease; several cases of arthritis following COVID-19 have been documented in the literature, such as reactive arthritis and chronic arthritis. We herein report a case of psoriatic arthritis triggered by COVID-19. Although the arthritis had been refractory to glucocorticoids and methotrexate, certolizumab pegol subsequently led to remission.
Keywords: COVID-19; certolizumab pegol; psoriatic arthritis; severe acute respiratory syndrome coronavirus 2.
【저자키워드】 COVID-19, severe acute respiratory syndrome coronavirus 2, psoriatic arthritis, certolizumab pegol, 【초록키워드】 coronavirus disease, Arthritis, viral infection, coronavirus, glucocorticoid, Spread, Patient, Autoimmune, methotrexate, manifestation, acute respiratory syndrome, poor prognosis, mild-to-moderate disease, reactive, develop, caused, induce, triggered, 【제목키워드】 certolizumab pegol, refractory,